Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases.

Miranda-Duarte A, Kraus-Weisman A, Granados J, Vill AR.

Rev Invest Clin. 2011 May-Jun;63(3):236-43.

PMID:
21888287
2.

HLA-DRB1 genes in 5 rheumatic disease multi-case families.

Tian X, Jiang M, Qiu C.

Chin Med J (Engl). 1998 Mar;111(3):208-10.

PMID:
10374416
3.

Malignancies in autoimmune rheumatic diseases - a mini-review.

Szekanecz Z, Szekanecz E, Bakó G, Shoenfeld Y.

Gerontology. 2011;57(1):3-10. doi: 10.1159/000314634. Epub 2010 May 7. Review.

4.

Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.

Delgado-Vega AM, Castiblanco J, Gómez LM, Diaz-Gallo LM, Rojas-Villarraga A, Anaya JM.

Ann Rheum Dis. 2010 Feb;69(2):462-5. doi: 10.1136/ard.2008.100818. Epub 2009 Mar 11.

PMID:
19282307
6.

Study of class I and II HLA alleles in 30 ecuadorian patients with rheumatoid arthritis compared with alleles from healthy and affected subjects with other rheumatic diseases.

Arias MV, Domingues EV, Lozano RB, Flores CV, Peralta MM, Salinas CZ.

Rev Bras Reumatol. 2010 Jul-Aug;50(4):423-33. English, Portuguese.

PMID:
21125177
7.

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA.

Neurology. 2005 Jan 11;64(1):44-9.

PMID:
15642902
8.

Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution.

Villa AR, Kraus A, Jiménez-Corona A, Sandino S, Velázquez-González A, Granados J, Alarcón-Segovia D.

J Clin Rheumatol. 2000 Aug;6(4):176-83.

PMID:
19078467
9.

Rheumatic syndromes: clues to occult neoplasia.

Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D.

Semin Arthritis Rheum. 1999 Aug;29(1):43-55. Review.

PMID:
10468414
10.

The dual association between lymphoma and autoimmunity.

Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):750-6. Review.

PMID:
11778659
11.

Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.

Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.

J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.

PMID:
18085741
12.

Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece.

Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, Germenis A, Adam K, Taparkou A, Siamopoulou A, Drakou C, Konstantinidis T, Prieur AM, Stavropoulos-Giokas C.

Eur J Immunogenet. 1999 Aug;26(4):299-310.

PMID:
10457895
13.

MHC Class II alleles in ulcerative colitis-associated colorectal cancer.

Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC.

Gut. 2009 Sep;58(9):1226-33. doi: 10.1136/gut.2008.166686. Epub 2009 Feb 26.

PMID:
19251712
14.

The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.

Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.

Arthritis Rheum. 2009 Mar;60(3):698-707. doi: 10.1002/art.24353.

15.

Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles.

Haydardedeoğlu FE, Tutkak H, Köse K, Düzgün N.

Tissue Antigens. 2006 Oct;68(4):293-6.

PMID:
17026463
16.

Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans.

Hong GH, Kim HY, Takeuchi F, Nakano K, Yamada H, Matsuta K, Han H, Tokunaga K, Ito K, Park KS.

J Rheumatol. 1994 Mar;21(3):442-7.

PMID:
7911834
17.

Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.

Nakao S, Takamatsu H, Chuhjo T, Ueda M, Shiobara S, Matsuda T, Kaneshige T, Mizoguchi H.

Blood. 1994 Dec 15;84(12):4257-61.

PMID:
7994040
18.

Malignancy and autoimmunity.

Bernatsky S, Ramsey-Goldman R, Clarke A.

Curr Opin Rheumatol. 2006 Mar;18(2):129-34. Review.

PMID:
16462517
19.

Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.

Khani-Hanjani A, Lacaille D, Horne C, Chalmers A, Hoar DI, Balshaw R, Keown PA.

J Rheumatol. 2002 Jul;29(7):1358-65.

PMID:
12136889
20.

[Tumors in rheumatic diseases].

Świerkot J, Lewandowicz-Uszyńska A, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2013 Dec 11;67:1254-60. Review. Polish.

Supplemental Content

Support Center